pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    GFH-375
    Colorectal Cancer$VSTM Verastem, Inc.
  • Preclinical
    GH-3595
    Solid Tumor Suzhou GenHouse Pharmaceutical Co Ltd
  • Phase 2
    GI-102
    Metastatic Melanoma GI Innovation Co Ltd
  • Phase 1
← prev
page 20 of 62
next →
Pain89
Neurology1
GIGA-564
Solid Tumor
GigaGen Inc
  • Phase 2
    GIM-122
    Solid Tumor Georgiamune Inc
  • Phase 2
    GIM-531
    Metastatic Melanoma Georgiamune Inc
  • Phase 2
    GLIX-1
    High-Grade Glioma Tetragon Biosciences Ltd
  • Preclinical
    GLR-2007
    Malignant Glioma Gan & Lee Pharmaceuticals Co Ltd
  • Preclinical
    GNTbm-TKI
    Neuroendocrine Tumors Great Novel Therapeutics Biotech & Medicals Corp
  • Phase 2
    GO-2032c
    Refractory Acute Myeloid Leukemia Genus Oncology LLC
  • Phase 3
    GP-2
    Human Epidermal Growth Factor Receptor 2 Positive Breast…$GLSI Greenwich LifeSciences, Inc.
  • Phase 2
    GRC-54276
    Bile Duct Cancer (Cholangiocarcinoma) Ichnos Glenmark Innovation
  • Phase 1
    GRN-300
    Triple-Negative Breast Cancer (TNBC) Greenfire Bio LLC
  • Phase 1
    GS-0321
    Solid Tumor$GILD GILEAD SCIENCES, INC.
  • Phase 2
    GSK-101
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance…$GSK GSK plc
  • Phase 1
    GTB-3650
    Myelodysplastic Syndrome (Preleukemia)$GTBP GT Biopharma, Inc.
  • Phase 1
    GTB-5550
    Epithelial Ovarian Cancer$GTBP GT Biopharma, Inc.
  • Phase 2
    GV-200251
    Cervical Cancer GV20 Therapeutics LLC
  • Preclinical
    GW-01
    Unspecified Cancer Groovy Medicine Inc
  • Phase 1
    Gallium Maltolate
    Recurrent Glioblastoma Multiforme (GBM)$KMCM Titan Holdings Corp.
  • Preclinical
    Gene Therapy to Target BCMA and CS1 for Multiple Myeloma
    Multiple Myeloma (Kahler Disease) University of California Los Angeles
  • Phase 1
    Gene Therapy to Target CD22 for Oncology
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… National Cancer Institute US
  • Preclinical
    GlyTR1 Bi-specific Protein
    Solid Tumor GlyTR Therapeutics Inc
  • Phase 2
    H-002
    Non-Small Cell Lung Cancer RedCloud Bio Inc
  • Phase 1
    H-3B6545
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Eisai Co Ltd
  • Phase 1
    HBM-1020
    Metastatic Colorectal Cancer Harbour BioMed (Guangzhou) Co Ltd
  • Phase 1
    HCB-301
    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) HanchorBio Inc
  • Phase 2
    HCW-9218
    Metastatic Pancreatic Cancer$HCWB HCW Biologics Inc.
  • Phase 1
    HF-158K1
    Bladder Cancer HighField Biopharmaceuticals, Inc.
  • Phase 1
    HFB-200603
    Colorectal Cancer HiFiBiO Therapeutics Inc